Cargando…
Refractory Sjögren's syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report
RATIONALE: It is known that 5% to 34% of Sjögren's syndrome (SS) cases are complicated by neuropathy in the form of myelitis. Although SS myelopathy (SSM) is often treated with glucocorticoid (GC) and immunosuppressants such as cyclophosphamide (CY), a therapeutic strategy for SSM has not been...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635267/ https://www.ncbi.nlm.nih.gov/pubmed/31277158 http://dx.doi.org/10.1097/MD.0000000000016285 |